Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Valerio Therapeutics
- Target Recruit Count
- 121
- Registration Number
- NCT00413075
- Locations
- πΊπΈ
New York University Cancer Institute, New York, New York, United States
πΊπΈYale New Haven Hospital, New Haven, Connecticut, United States
π¬π§Research Facility, London, Surrey, United Kingdom
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Valerio Therapeutics
- Target Recruit Count
- 35
- Registration Number
- NCT00413322
- Locations
- πΊπΈ
Mayo Clinic Arizona, Scottsdale, Arizona, United States
πΊπΈPortsmouth Regional Hospital Hematology/Oncology Clinic, Portsmouth, New Hampshire, United States
πΊπΈUniversity of Nebraska, Omaha, Nebraska, United States
Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
- First Posted Date
- 2006-10-20
- Last Posted Date
- 2013-09-16
- Lead Sponsor
- Valerio Therapeutics
- Target Recruit Count
- 578
- Registration Number
- NCT00390780
- Locations
- π¨π¦
Montreal General Hospital, Montreal, Quebec, Canada
π¨π¦University of Ottawa Health Services, Ottawa, Ontario, Canada
πΊπΈUniversity of Connecticut, School of dental medicine, Farmington, Connecticut, United States
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
- Conditions
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Valerio Therapeutics
- Target Recruit Count
- 53
- Registration Number
- NCT00274651
- Locations
- πΊπΈ
Leland Stanford Junior University, Stanford, California, United States
πΊπΈNYU Medical Center, New York, New York, United States
πΊπΈCleveland Clinic Foundation, Cleveland, Ohio, United States
Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma
- Conditions
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Valerio Therapeutics
- Target Recruit Count
- 25
- Registration Number
- NCT00131261
- Locations
- πΊπΈ
Northwestern University, Chicago, Illinois, United States
π¬π§Christie Hospital NHS Trust, Manchester, United Kingdom
π¬π§The Royal Marsden NHS Trust, Surrey, United Kingdom